Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calogero Vetro

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Cancer Biology & Therapy|April 9, 2011
Advances in understanding regulatory myeloid cellsAlessandra Romano, Calogero Vetro, Marsilio Adriani
Expert Opinion on Pharmacotherapy|June 21, 2023
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitorsAndrea Duminuco, Calogero Vetro, Cesarina Giallongo, et al.
Endocrine|August 18, 2009
Adrenal morphology and function in acromegalic patients in relation to disease activityAlessandro Ciresi, Marco C Amato, Calogero Vetro, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
Thyroid : Official Journal of the American Thyroid Association|September 6, 2012
Neck lymph nodes in chronic autoimmune thyroiditis: the sonographic patternDavide Brancato, Roberto Citarrella, Pierina Richiusa, et al.
Current Hematologic Malignancy Reports|May 3, 2025
Emerging Therapeutic Approaches for Anemia in MyelofibrosisHelen T Chifotides, Andrea Duminuco, Elena Torre, et al.
Biomed Research International|July 12, 2014
Immunological dysregulation in multiple myeloma microenvironmentAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2014
Immunological deregulation in classic hodgkin lymphomaAlessandra Romano, Calogero Vetro, Giovanni Caocci, et al.
Leukemia|November 14, 2019
Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemiaLuise Hartmann, Niroshan Nadarajah, Manja Meggendorfer, et al.
Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Cancer Biology & Therapy|April 9, 2011
Advances in understanding regulatory myeloid cellsAlessandra Romano, Calogero Vetro, Marsilio Adriani
Expert Opinion on Pharmacotherapy|June 21, 2023
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitorsAndrea Duminuco, Calogero Vetro, Cesarina Giallongo, et al.
Endocrine|August 18, 2009
Adrenal morphology and function in acromegalic patients in relation to disease activityAlessandro Ciresi, Marco C Amato, Calogero Vetro, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
Thyroid : Official Journal of the American Thyroid Association|September 6, 2012
Neck lymph nodes in chronic autoimmune thyroiditis: the sonographic patternDavide Brancato, Roberto Citarrella, Pierina Richiusa, et al.
Current Hematologic Malignancy Reports|May 3, 2025
Emerging Therapeutic Approaches for Anemia in MyelofibrosisHelen T Chifotides, Andrea Duminuco, Elena Torre, et al.
Biomed Research International|July 12, 2014
Immunological dysregulation in multiple myeloma microenvironmentAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2014
Immunological deregulation in classic hodgkin lymphomaAlessandra Romano, Calogero Vetro, Giovanni Caocci, et al.
Leukemia|November 14, 2019
Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemiaLuise Hartmann, Niroshan Nadarajah, Manja Meggendorfer, et al.
Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.
Pageof 7